Yüklüyor......
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease
Disease outcomes are heterogeneous in Parkinson’s disease and may be predicted by gene variants. This study investigated if the BDNF rs6265 single nucleotide polymorphism (SNP) is associated with differential outcomes with specific pharmacotherapy treatment strategies in the “NIH Exploratory Trials...
Kaydedildi:
| Yayımlandı: | Neurotherapeutics |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7851242/ https://ncbi.nlm.nih.gov/pubmed/33215284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00965-9 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|